Indication
NLRP3
1 clinical trial
3 products
Clinical trial
Effect of Inflammasome Inhibitor on High-sensitivity C-reactive Protein in Patients After Percutaneous Coronary InterventionStatus: Completed, Estimated PCD: 2023-02-01
Product
ColchicineProduct
TranilastProduct
Oridonin